The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 10 of 15
Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
NCT02935595
Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free Gingival Graft Donor Site
NCT03713073
Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter
NCT02943226
Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home
NCT02870387
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
NCT02918630
Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
NCT02864862
Teens Against Tobacco Use: A Tobacco Prevention Curriculum and Advocacy Initiative
NCT02926339
Subarachnoid Hemorrhage Recovery And Galantamine
NCT02872857
Patient Centered Outcomes Study
NCT04355819
Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis
NCT02466074
An Integrative Approach to Improve Child Outcomes Through Research-based Parent and Teacher Interventions
NCT03431545
Stem Cell Injection in Cancer Survivors
NCT02509156
ToRsemide for pOstpartum HYpertension
NCT02813551
Biobehavioral Effects of Therapy Dog Visitation in Elderly Intensive Care Unit Patients: A Pilot and Feasibility Study
NCT02997852
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
NCT02573402
Damage Control Laparotomy
NCT02706041
Rehab MATRIX: Impact of a Nursing-Led Acuity Algorithm on Patient Safety and Healthcare Quality
NCT02850952
Exenatide Once Weekly for Smoking Cessation
NCT02975297
Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting
NCT03473171
Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
NCT02837536
Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis
NCT02806297
Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
NCT02702999
Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively
NCT02748525
Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use
NCT02785406
Effects of Combined Spinal Direct Current Stimulation on Upper Limb Recovery in Acquired Brain Injury
NCT03100370
BreEStim and tDCS for Neuropathic Pain Management - Healthy Subjects
NCT03302780
The Comparative Effectiveness of Liberal Versus Restricted Maternal Administration of Oxygen During Labor
NCT02752490
Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
NCT02664220
Comparative Utility of Clinical Balance Measures in Traumatic Brain Injury
NCT02696538
The neoClose Abdominal Closure vs Carter-Thomason Trial
NCT02589171
Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction
NCT03704376
Extended Criteria For Fetal Myelomeningocele Repair
NCT02664207
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
NCT02560012
Cord Clamping Level Above or Below Mother's Perineum
NCT02659605
Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial
NCT02639429
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
NCT02446587
Prospective Tumor Response Evaluation
NCT02787954
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
NCT02761928
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
NCT02247193
Transcranial Direct Current Stimulation in Older Persons With Knee Pain (Knee Pain and tDCS): Randomized Pilot Study
NCT02512393
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
NCT02560051
STEPs to Blood Pressure Reduction.
NCT02591394
Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites
NCT03350724
Prevention Program to Reduce Injury Disparities Among Latino Day Laborers
NCT04378348
Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure
NCT02501811
The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease
NCT02544984
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
NCT02494713
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
NCT02560038
Longitudinal Evaluation of Teens Against Tobacco Use
NCT02535559
Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention
NCT02600884
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.